Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evidence for increased chylomicron remnants in rheumatoid arthritis.
Burggraaf B, van Breukelen-van der Stoep DF, van Zeben J, van der Meulen N, van de Geijn GM, Liem A, Valdivielso P, Rioja Villodres J, Ramírez-Bollero J, van der Zwan E, Castro Cabezas M. Burggraaf B, et al. Among authors: van breukelen van der stoep df. Eur J Clin Invest. 2018 Feb;48(2). doi: 10.1111/eci.12873. Epub 2018 Jan 8. Eur J Clin Invest. 2018. PMID: 29231984 Clinical Trial.
Progression of subclinical atherosclerosis in subjects with rheumatoid arthritis and the metabolic syndrome.
Burggraaf B, van Breukelen-van der Stoep DF, de Vries MA, Klop B, van Zeben J, van de Geijn GM, van der Meulen N, Birnie E, Prinzen L, Castro Cabezas M. Burggraaf B, et al. Among authors: van breukelen van der stoep df. Atherosclerosis. 2018 Apr;271:84-91. doi: 10.1016/j.atherosclerosis.2018.02.019. Epub 2018 Feb 17. Atherosclerosis. 2018. PMID: 29482038 Clinical Trial.
Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial.
Burggraaf B, van Breukelen-van der Stoep DF, de Vries MA, Klop B, Liem AH, van de Geijn GM, van der Meulen N, Birnie E, van der Zwan EM, van Zeben J, Castro Cabezas M. Burggraaf B, et al. Among authors: van breukelen van der stoep df. Ann Rheum Dis. 2019 Mar;78(3):335-341. doi: 10.1136/annrheumdis-2018-214075. Epub 2019 Jan 4. Ann Rheum Dis. 2019. PMID: 30610067 Clinical Trial.
Association of Cardiovascular Risk Factors with Carotid Intima Media Thickness in Patients with Rheumatoid Arthritis with Low Disease Activity Compared to Controls: A Cross-Sectional Study.
van Breukelen-van der Stoep DF, van Zeben D, Klop B, van de Geijn GJ, Janssen HJ, Hazes MJ, Birnie E, van der Meulen N, De Vries MA, Castro Cabezas M. van Breukelen-van der Stoep DF, et al. PLoS One. 2015 Oct 20;10(10):e0140844. doi: 10.1371/journal.pone.0140844. eCollection 2015. PLoS One. 2015. PMID: 26485681 Free PMC article.
Cardiovascular risk in rheumatoid arthritis: how to lower the risk?
van Breukelen-van der Stoep DF, Klop B, van Zeben D, Hazes JM, Castro Cabezas M. van Breukelen-van der Stoep DF, et al. Atherosclerosis. 2013 Nov;231(1):163-72. doi: 10.1016/j.atherosclerosis.2013.09.006. Epub 2013 Sep 20. Atherosclerosis. 2013. PMID: 24125429 Review.